Cwm LLC Sells 1,111 Shares of Cardinal Health, Inc. (NYSE:CAH)

Cwm LLC trimmed its holdings in Cardinal Health, Inc. (NYSE:CAH) by 8.9% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,389 shares of the company’s stock after selling 1,111 shares during the period. Cwm LLC’s holdings in Cardinal Health were worth $1,259,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. Cultivar Capital Inc. acquired a new position in Cardinal Health during the second quarter worth $27,000. Ashton Thomas Private Wealth LLC bought a new position in shares of Cardinal Health in the 2nd quarter valued at approximately $29,000. LRI Investments LLC acquired a new stake in Cardinal Health in the 1st quarter worth approximately $32,000. Palisade Asset Management LLC bought a new stake in Cardinal Health during the first quarter worth approximately $34,000. Finally, New Covenant Trust Company N.A. acquired a new position in Cardinal Health during the first quarter valued at approximately $40,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insiders Place Their Bets

In other news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total value of $1,905,566.08. Following the sale, the insider now directly owns 94,529 shares in the company, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other Cardinal Health news, insider Jessica L. Mayer sold 16,573 shares of Cardinal Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the completion of the transaction, the insider now directly owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Jessica L. Mayer sold 17,896 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now owns 94,529 shares in the company, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 113,963 shares of company stock worth $12,379,980 over the last quarter. Company insiders own 0.15% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Wells Fargo & Company boosted their price objective on shares of Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a research note on Thursday, August 15th. StockNews.com upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft lifted their price objective on Cardinal Health from $115.00 to $119.00 and gave the stock a “hold” rating in a research note on Friday, August 16th. JPMorgan Chase & Co. increased their target price on Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. Finally, UBS Group lifted their price target on Cardinal Health from $120.00 to $125.00 and gave the stock a “buy” rating in a research report on Thursday, August 15th. One research analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $119.36.

Cardinal Health Trading Up 0.5 %

Shares of NYSE:CAH opened at $112.55 on Thursday. The firm has a market capitalization of $27.41 billion, a PE ratio of 50.02, a PEG ratio of 1.57 and a beta of 0.60. Cardinal Health, Inc. has a 1-year low of $90.19 and a 1-year high of $116.05. The business’s 50 day moving average is $110.50 and its 200-day moving average is $103.95.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 14th. The company reported $1.84 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10. Cardinal Health had a net margin of 0.37% and a negative return on equity of 54.85%. The firm had revenue of $59.87 billion for the quarter, compared to the consensus estimate of $58.74 billion. During the same quarter in the previous year, the company earned $1.55 earnings per share. The business’s revenue was up 12.1% compared to the same quarter last year. On average, sell-side analysts predict that Cardinal Health, Inc. will post 7.61 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were given a $0.506 dividend. This represents a $2.02 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend was Tuesday, October 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s dividend payout ratio is 89.78%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.